EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 192, Issue 12, Pages 1712-1724
Publisher
Elsevier BV
Online
2022-11-29
DOI
10.1016/j.ajpath.2022.08.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholangiocarcinoma
- (2021) Paul J. Brindley et al. Nature Reviews Disease Primers
- The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway
- (2020) Wenbo Ma et al. HEPATOLOGY
- The Tumor Microenvironment in Cholangiocarcinoma Progression
- (2020) Luca Fabris et al. HEPATOLOGY
- Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
- (2020) Min Zhang et al. JOURNAL OF HEPATOLOGY
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Cholangiocarcinoma: Epidemiology and risk factors
- (2019) Shahid A. Khan et al. LIVER INTERNATIONAL
- Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma
- (2019) Wiphawan Wasenang et al. PATHOLOGY RESEARCH AND PRACTICE
- Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach
- (2019) Keun Soo Ahn et al. Hepatology International
- The biochemical basis of microRNA targeting efficacy
- (2019) Sean E. McGeary et al. SCIENCE
- Epigenome dysregulation in cholangiocarcinoma
- (2018) Colm J. O'Rourke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The expression and function of PAX3 in development and disease
- (2018) Salah Boudjadi et al. GENE
- Allosteric Activation Dictates PRC2 Activity Independent of Its Recruitment to Chromatin
- (2018) Chul-Hwan Lee et al. MOLECULAR CELL
- Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma
- (2018) Shigeki Nakagawa et al. HPB
- Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
- (2018) Yang Yu et al. Cell Death & Disease
- HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium
- (2018) Yun-Fei Xu et al. ONCOGENE
- Noncoding RNA in Cholangiocarcinoma
- (2018) Massimiliano Salati et al. SEMINARS IN LIVER DISEASE
- Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
- (2018) Jung Kim et al. Cell Reports
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- An interactive environment for agile analysis and visualization of ChIP-sequencing data
- (2016) Mads Lerdrup et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- An interactive environment for agile analysis and visualization of ChIP-sequencing data
- (2016) Mads Lerdrup et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer
- (2016) Wei Liu et al. Oncotarget
- Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
- (2016) Ludovica Morera et al. Clinical Epigenetics
- Gas1 is a Pleiotropic Regulator of Cellular Functions: from Embryonic Development to Molecular Actions in Cancer Gene Therapy
- (2015) Jose Segovia et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma
- (2015) Yun-Fei Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Allele-Specific Imbalance of Oxidative Stress-Induced Growth Inhibitor 1 Associates With Progression of Hepatocellular Carcinoma
- (2014) Ming Liu et al. GASTROENTEROLOGY
- EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3
- (2014) Bo Tang et al. MEDICAL ONCOLOGY
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
- (2013) Shigeki Nakagawa et al. ANNALS OF SURGICAL ONCOLOGY
- EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
- (2013) J. Yan et al. BLOOD
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
- (2013) Hae-Yun Jung et al. MOLECULAR CELL
- Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
- (2013) SHIGEKI NAKAGAWA et al. ONCOLOGY REPORTS
- Epigenetic alteration and microRNA dysregulation in cancer
- (2013) Hiromu Suzuki et al. Frontiers in Genetics
- Classification, Diagnosis, and Management of Cholangiocarcinoma
- (2012) Nataliya Razumilava et al. Clinical Gastroenterology and Hepatology
- Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct
- (2012) Motoko Sasaki et al. HISTOPATHOLOGY
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone methylation: a dynamic mark in health, disease and inheritance
- (2012) Eric L. Greer et al. NATURE REVIEWS GENETICS
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- Targeted Overexpression of EZH2 in the Mammary Gland Disrupts Ductal Morphogenesis and Causes Epithelial Hyperplasia
- (2009) Xin Li et al. AMERICAN JOURNAL OF PATHOLOGY
- The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
- (2008) Motoko Sasaki et al. LABORATORY INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now